doi: 10.3389/fmicb.2020.01543
Tissue repair Studied preclinically as a pentadecapeptide involved in tissue repair, with animal research exploring wound-healing and cellular recovery pathways
Consider a company which guarantees their products
The mechanistic logic of complementarity (angiogenesis + cell migration) is plausible but relies on theoretical extrapolation
MOTS-C promotes fat oxidation through AMPK-mediated lipolysis and targets visceral fat specifically
HGF targeting antibodies, including rilotumumab (AMG-102), ficlatuzumab, TAK-701, and YYB-101, bind to HGF and prevent c-Met attachment, leading to the induction of synergistic anti-tumor responses combined with other TKIs and EGFR inhibitors [162, 172, 178, 179]